Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
eli lilly
life sciences
merck
3
×
migraine
3
×
national
national blog main
national top stories
new york blog main
abbvie
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
detroit blog main
detroit top stories
fda
gene therapy
indiana blog main
indiana top stories
medicare
new york top stories
nivolumab
pembrolizumab
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
adalimumab (humira)
What
bio
companies
new
roundup
adults
allergan
approval
approved
arena’s
biogen’s
biopharmaceutical
bounty
cig
class
comeback
convo
corner
deals
delivered
drug
earlier
expressing
failures
fda
ipo
life
littered
little
medicines
migraine
moderna’s
monday
nash
news
nod
number
pill
price
remains
road
Language
unset
Current search:
migraine
×
merck
×
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
